To reveal upstream and downstream gene candidates of NANOG in AML we performed comparative expression analysis of public profiling data from AML patients with normal karyotype (S6A Fig) and AML cell lines (S6B Fig). This evidence concerns the gene NANOG and acute myeloid leukemia.